Found 12 matching trials
CT18 Infant Influenza Priming Study in Vaccine Naive Infants
PHASE2This study evaluates whether priming influenza naive infants, age six to 23...
Location
Vaccine Evaluation Center, BC Children's Hospital
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents
PHASE3This study is a multi-center, randomized, double-blind Phase III clinical t...
Location
Multiple Locations
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
PHASE3A phase III clinical trial of the study of quadrivalent influenza vaccine d...
Location
Huoqiu County Center for Disease Control and Prevention
Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
PHASE2To evaluate the immunogenicity and safety of 2 doses of quadrivalent influe...
Location
Henan Provincial Center for Disease Control and Prevention
Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .
PHASE3This is a Phase III Randomized Clinical Trial, blind, multicenter, with act...
Location
Instituto Auto Imune de Pesquisa e Educação Continuada - Real Hospital Português de Beneficência em Pernambuco (Site REC01)
A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months
PHASE3A random, blind and positive control design was adopted.the investigators w...
Location
Ab&b Biotechnology Co., Ltd.JS
Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)
PHASE3The purpose of this study is to evaluate the safety and immunogenicity of q...
Location
Guanyun Center for Disease Prevention and Control
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
PHASE3If study subject's legal guardians who decide voluntarily to participate th...
Location
The Catholic Univ.of Korea Seoul St.Mary's Hospital
Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months
PHASE3This study assesses immunogenicity and safety of NBP607-QIV to Agrippal whi...
Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine
PHASE3A randomized, blind, positive vaccine control trial was designed.A total of...
Location
Hunan Provincial Center for Disease Control and Prevention